Listed

Guardant Health, Inc.

GHNasdaqCIK 1576280HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$335.0m, Q2 FY2026
Operating income−$129.1m, Q2 FY2026
Net income−$120.1m, Q2 FY2026
Guardant Health, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m143Revenue, Q3 FY2023, three months to 2023-09-30$143.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure155Revenue, Q4 FY2023, three months to 2023-12-31$155.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure168Revenue, Q1 FY2024, three months to 2024-03-31$168.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure177Revenue, Q2 FY2024, three months to 2024-06-30$177.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure191Revenue, Q3 FY2024, three months to 2024-09-30$191.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure202Revenue, Q4 FY2024, three months to 2024-12-31$201.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure203Revenue, Q1 FY2025, three months to 2025-03-31$203.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure232Revenue, Q2 FY2025, three months to 2025-06-30$232.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure265Revenue, Q3 FY2025, three months to 2025-09-30$265.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure281Revenue, Q4 FY2025, three months to 2025-12-31$281.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure302Revenue, Q1 FY2026, three months to 2026-03-31$301.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure335Revenue, Q2 FY2026, three months to 2026-06-30$335.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Cost of revenue$mnot reportednot reported65.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$65.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure72.4Cost of revenue, Q2 FY2024, three months to 2024-06-30$72.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure74.5Cost of revenue, Q3 FY2024, three months to 2024-09-30$74.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure77.6Cost of revenue, Q4 FY2024, three months to 2024-12-31$77.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure74.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$74.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure81.2Cost of revenue, Q2 FY2025, three months to 2025-06-30$81.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure93.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$93.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure99.5Cost of revenue, Q4 FY2025, three months to 2025-12-31$99.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure105Cost of revenue, Q1 FY2026, three months to 2026-03-31$104.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure116Cost of revenue, Q2 FY2026, three months to 2026-06-30$115.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Research and development$m93.9Research and development, Q3 FY2023, three months to 2023-09-30$93.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure89.9Research and development, Q4 FY2023, three months to 2023-12-31$89.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure83.8Research and development, Q1 FY2024, three months to 2024-03-31$83.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure83.1Research and development, Q2 FY2024, three months to 2024-06-30$83.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure87.3Research and development, Q3 FY2024, three months to 2024-09-30$87.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure93.5Research and development, Q4 FY2024, three months to 2024-12-31$93.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure88.5Research and development, Q1 FY2025, three months to 2025-03-31$88.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure87.4Research and development, Q2 FY2025, three months to 2025-06-30$87.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure90.0Research and development, Q3 FY2025, three months to 2025-09-30$90.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure98.3Research and development, Q4 FY2025, three months to 2025-12-31$98.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure91.0Research and development, Q1 FY2026, three months to 2026-03-31$91.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure96.5Research and development, Q2 FY2026, three months to 2026-06-30$96.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Operating income$m(114)Operating income, Q3 FY2023, three months to 2023-09-30−$113.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure(198)Operating income, Q4 FY2023, three months to 2023-12-31−$197.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(99.7)Operating income, Q1 FY2024, three months to 2024-03-31−$99.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure(101)Operating income, Q2 FY2024, three months to 2024-06-30−$100.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure(117)Operating income, Q3 FY2024, three months to 2024-09-30−$117.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure(126)Operating income, Q4 FY2024, three months to 2024-12-31−$126.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(111)Operating income, Q1 FY2025, three months to 2025-03-31−$111.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(106)Operating income, Q2 FY2025, three months to 2025-06-30−$106.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(99.0)Operating income, Q3 FY2025, three months to 2025-09-30−$99.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure(121)Operating income, Q4 FY2025, three months to 2025-12-31−$120.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(121)Operating income, Q1 FY2026, three months to 2026-03-31−$121.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(129)Operating income, Q2 FY2026, three months to 2026-06-30−$129.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Interest expense$m0.6Interest expense, Q3 FY2023, three months to 2023-09-30$644.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-06, accession 0001576280-23-000187.Report this figure0.6Interest expense, Q4 FY2023, three months to 2023-12-31$645.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-22, accession 0001576280-24-000043. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2024, three months to 2024-03-31$645.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001576280-24-000109.Report this figure0.6Interest expense, Q2 FY2024, three months to 2024-06-30$645.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure0.6Interest expense, Q3 FY2024, three months to 2024-09-30$646.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure0.6Interest expense, Q4 FY2024, three months to 2024-12-31$645.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.8Interest expense, Q1 FY2025, three months to 2025-03-31$791.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure1.0Interest expense, Q2 FY2025, three months to 2025-06-30$983.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure0.9Interest expense, Q3 FY2025, three months to 2025-09-30$943.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure1.2Interest expense, Q4 FY2025, three months to 2025-12-31$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure1.3Interest expense, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure1.3Interest expense, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Income tax$m0.5Income tax, Q3 FY2023, three months to 2023-09-30$490.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure(0.5)Income tax, Q4 FY2023, three months to 2023-12-31−$541.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2024, three months to 2024-03-31$405.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$133.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$30.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure0.7Income tax, Q4 FY2024, three months to 2024-12-31$716.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q1 FY2025, three months to 2025-03-31$290.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$38.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure0.1Income tax, Q3 FY2025, three months to 2025-09-30$136.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure(1.7)Income tax, Q4 FY2025, three months to 2025-12-31−$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2026, three months to 2026-03-31$372.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure0.2Income tax, Q2 FY2026, three months to 2026-06-30$185.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Net income$m(86.1)Net income, Q3 FY2023, three months to 2023-09-30−$86.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure(187)Net income, Q4 FY2023, three months to 2023-12-31−$187.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(115)Net income, Q1 FY2024, three months to 2024-03-31−$115.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure(103)Net income, Q2 FY2024, three months to 2024-06-30−$102.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure(108)Net income, Q3 FY2024, three months to 2024-09-30−$107.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure(111)Net income, Q4 FY2024, three months to 2024-12-31−$111.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(95.2)Net income, Q1 FY2025, three months to 2025-03-31−$95.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(99.9)Net income, Q2 FY2025, three months to 2025-06-30−$99.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(92.7)Net income, Q3 FY2025, three months to 2025-09-30−$92.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure(128)Net income, Q4 FY2025, three months to 2025-12-31−$128.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(112)Net income, Q1 FY2026, three months to 2026-03-31−$112.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(120)Net income, Q2 FY2026, three months to 2026-06-30−$120.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Diluted EPS$ per share(0.73)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figurenot reported(0.94)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure(0.84)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure(0.88)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figurenot reported(0.77)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(0.80)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(0.74)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figurenot reported(0.85)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(0.90)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Basic EPS$ per share(0.73)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figurenot reported(0.94)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure(0.84)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure(0.88)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figurenot reported(0.77)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(0.80)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(0.74)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figurenot reported(0.85)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(0.90)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure

Balance sheet

Cash and equivalents$1.05bn, Q2 FY2026
Long-term debt$1.50bn, Q2 FY2026
Shareholders' equity−$222.9m, Q2 FY2026
Guardant Health, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m457Cash and equivalents, Q3 FY2023, at 2023-09-30$457.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure1,134Cash and equivalents, FY2023, at 2023-12-31$1.13bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-19, accession 0001576280-26-000013.Report this figure1,029Cash and equivalents, Q1 FY2024, at 2024-03-31$1.03bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure934Cash and equivalents, Q2 FY2024, at 2024-06-30$933.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure585Cash and equivalents, Q3 FY2024, at 2024-09-30$585.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure526Cash and equivalents, FY2024, at 2024-12-31$525.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-19, accession 0001576280-26-000013.Report this figure699Cash and equivalents, Q1 FY2025, at 2025-03-31$698.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure629Cash and equivalents, Q2 FY2025, at 2025-06-30$629.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure580Cash and equivalents, Q3 FY2025, at 2025-09-30$580.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure378Cash and equivalents, FY2025, at 2025-12-31$378.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure989Cash and equivalents, Q1 FY2026, at 2026-03-31$989.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure1,053Cash and equivalents, Q2 FY2026, at 2026-06-30$1.05bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Current assets$m1,347Current assets, Q3 FY2023, at 2023-09-30$1.35bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001576280-23-000187.Report this figure1,347Current assets, FY2023, at 2023-12-31$1.35bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-20, accession 0001576280-25-000044.Report this figure1,309Current assets, Q1 FY2024, at 2024-03-31$1.31bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001576280-24-000109.Report this figure1,290Current assets, Q2 FY2024, at 2024-06-30$1.29bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001576280-24-000190.Report this figure1,227Current assets, Q3 FY2024, at 2024-09-30$1.23bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure1,055Current assets, FY2024, at 2024-12-31$1.06bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-19, accession 0001576280-26-000013.Report this figure927Current assets, Q1 FY2025, at 2025-03-31$927.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure883Current assets, Q2 FY2025, at 2025-06-30$883.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure829Current assets, Q3 FY2025, at 2025-09-30$828.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure1,466Current assets, FY2025, at 2025-12-31$1.47bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure1,368Current assets, Q1 FY2026, at 2026-03-31$1.37bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure1,365Current assets, Q2 FY2026, at 2026-06-30$1.36bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Total assets$m1,797Total assets, Q3 FY2023, at 2023-09-30$1.80bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001576280-23-000187.Report this figure1,786Total assets, FY2023, at 2023-12-31$1.79bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-20, accession 0001576280-25-000044.Report this figure1,705Total assets, Q1 FY2024, at 2024-03-31$1.70bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001576280-24-000109.Report this figure1,609Total assets, Q2 FY2024, at 2024-06-30$1.61bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001576280-24-000190.Report this figure1,539Total assets, Q3 FY2024, at 2024-09-30$1.54bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure1,486Total assets, FY2024, at 2024-12-31$1.49bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-19, accession 0001576280-26-000013.Report this figure1,344Total assets, Q1 FY2025, at 2025-03-31$1.34bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure1,332Total assets, Q2 FY2025, at 2025-06-30$1.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure1,277Total assets, Q3 FY2025, at 2025-09-30$1.28bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure2,014Total assets, FY2025, at 2025-12-31$2.01bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure1,915Total assets, Q1 FY2026, at 2026-03-31$1.92bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure1,912Total assets, Q2 FY2026, at 2026-06-30$1.91bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Current liabilities$m227Current liabilities, Q3 FY2023, at 2023-09-30$226.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001576280-23-000187.Report this figure206Current liabilities, FY2023, at 2023-12-31$205.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-20, accession 0001576280-25-000044.Report this figure220Current liabilities, Q1 FY2024, at 2024-03-31$220.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001576280-24-000109.Report this figure202Current liabilities, Q2 FY2024, at 2024-06-30$201.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001576280-24-000190.Report this figure197Current liabilities, Q3 FY2024, at 2024-09-30$197.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure226Current liabilities, FY2024, at 2024-12-31$225.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-19, accession 0001576280-26-000013.Report this figure226Current liabilities, Q1 FY2025, at 2025-03-31$225.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure238Current liabilities, Q2 FY2025, at 2025-06-30$238.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure237Current liabilities, Q3 FY2025, at 2025-09-30$236.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure303Current liabilities, FY2025, at 2025-12-31$302.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure292Current liabilities, Q1 FY2026, at 2026-03-31$292.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure339Current liabilities, Q2 FY2026, at 2026-06-30$339.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Total liabilities$m1,569Total liabilities, Q3 FY2023, at 2023-09-30$1.57bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001576280-23-000187.Report this figure1,628Total liabilities, FY2023, at 2023-12-31$1.63bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-20, accession 0001576280-25-000044.Report this figure1,636Total liabilities, Q1 FY2024, at 2024-03-31$1.64bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001576280-24-000109.Report this figure1,611Total liabilities, Q2 FY2024, at 2024-06-30$1.61bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001576280-24-000190.Report this figure1,599Total liabilities, Q3 FY2024, at 2024-09-30$1.60bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure1,625Total liabilities, FY2024, at 2024-12-31$1.63bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-19, accession 0001576280-26-000013.Report this figure1,595Total liabilities, Q1 FY2025, at 2025-03-31$1.60bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure1,637Total liabilities, Q2 FY2025, at 2025-06-30$1.64bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure1,631Total liabilities, Q3 FY2025, at 2025-09-30$1.63bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure2,113Total liabilities, FY2025, at 2025-12-31$2.11bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure2,096Total liabilities, Q1 FY2026, at 2026-03-31$2.10bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure2,135Total liabilities, Q2 FY2026, at 2026-06-30$2.14bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported1,143Long-term debt, FY2024, at 2024-12-31$1.14bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-19, accession 0001576280-26-000013.Report this figure1,116Long-term debt, Q1 FY2025, at 2025-03-31$1.12bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure1,116Long-term debt, Q2 FY2025, at 2025-06-30$1.12bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure1,115Long-term debt, Q3 FY2025, at 2025-09-30$1.11bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure1,504Long-term debt, FY2025, at 2025-12-31$1.50bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure1,503Long-term debt, Q1 FY2026, at 2026-03-31$1.50bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure1,503Long-term debt, Q2 FY2026, at 2026-06-30$1.50bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure
Shareholders' equity$m228Shareholders' equity, Q3 FY2023, at 2023-09-30$228.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure159Shareholders' equity, FY2023, at 2023-12-31$158.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-19, accession 0001576280-26-000013.Report this figure68.3Shareholders' equity, Q1 FY2024, at 2024-03-31$68.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure(1.6)Shareholders' equity, Q2 FY2024, at 2024-06-30−$1.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure(60.1)Shareholders' equity, Q3 FY2024, at 2024-09-30−$60.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure(140)Shareholders' equity, FY2024, at 2024-12-31−$139.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(251)Shareholders' equity, Q1 FY2025, at 2025-03-31−$250.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(305)Shareholders' equity, Q2 FY2025, at 2025-06-30−$305.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(354)Shareholders' equity, Q3 FY2025, at 2025-09-30−$354.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure(99.3)Shareholders' equity, FY2025, at 2025-12-31−$99.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(181)Shareholders' equity, Q1 FY2026, at 2026-03-31−$181.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure(223)Shareholders' equity, Q2 FY2026, at 2026-06-30−$222.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure

Cash flow

Operating cash flow−$57.8m, Q2 FY2026
Capital expenditure$11.8m, Q2 FY2026
Share repurchases$0, Q2 FY2026
Guardant Health, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(77.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$77.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001576280-24-000261. Derived: 9-month figure less the 6-month figure.Report this figure(78.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$78.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(30.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$30.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure(94.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$94.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001576280-25-000246. Derived: 6-month figure less the 3-month figure.Report this figure(51.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$51.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001576280-25-000277. Derived: 9-month figure less the 6-month figure.Report this figure(64.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$64.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(62.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$62.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(60.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$60.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001576280-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure(35.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$35.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001576280-25-000277. Derived: 9-month figure less the 6-month figure.Report this figure(26.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$26.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(65.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$65.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure(57.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$57.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001576280-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m2.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001576280-24-000261. Derived: 9-month figure less the 6-month figure.Report this figure4.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure6.9Capital expenditure, Q1 FY2024, three months to 2024-03-31$6.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure5.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001576280-25-000246. Derived: 6-month figure less the 3-month figure.Report this figure4.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$4.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001576280-25-000277. Derived: 9-month figure less the 6-month figure.Report this figure18.9Capital expenditure, Q4 FY2024, three months to 2024-12-31$18.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure4.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$4.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure5.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$5.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001576280-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure10.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$10.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001576280-25-000277. Derived: 9-month figure less the 6-month figure.Report this figure27.8Capital expenditure, Q4 FY2025, three months to 2025-12-31$27.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure5.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure11.8Capital expenditure, Q2 FY2026, three months to 2026-06-30$11.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001576280-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reported0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-30, accession 0001576280-25-000246. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-29, accession 0001576280-25-000277. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure45.0Share repurchases, Q1 FY2025, three months to 2025-03-31$45.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-30, accession 0001576280-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-29, accession 0001576280-25-000277. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-19, accession 0001576280-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-30, accession 0001576280-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)132.87m, Q2 FY2026
Guardant Health, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares102Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30102,289,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001576280-23-000187.Report this figure103Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31102,663,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001576280-24-000109.Report this figure109Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30108,808,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001576280-24-000190.Report this figure118Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30117,736,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001576280-24-000261.Report this figure122Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31121,712,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-30, accession 0001576280-25-000136.Report this figure122Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30122,447,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0001576280-25-000246.Report this figure123Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30123,051,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure124Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31123,871,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure124Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30124,114,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure125Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30124,807,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-29, accession 0001576280-25-000277.Report this figure131Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31131,273,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001576280-26-000026.Report this figure133Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30132,867,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure

Shares outstanding: 134.20mShares outstanding, period not labelled, at 2026-07-24134,196,170 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-30, accession 0001576280-26-000037.Report this figure at Jul 24, 2026, from the cover of the 10-Q filed Jul 30, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.